Welcome to our dedicated page for Veeva Sys news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Sys stock.
Veeva Systems Inc. reports developments in cloud software, data, AI, and consulting for the life sciences industry. Company news commonly covers adoption of the Veeva Vault Platform, including Development Cloud, Quality Cloud, Commercial Cloud, Data Cloud, Vault CRM, and Veeva MedTech applications for clinical, regulatory, quality, commercial, and medical operations.
Updates also include customer standardization projects with pharmaceutical, biotechnology, medical device, and diagnostics companies; product and data offerings such as Link Key People and Veeva AI; fiscal results and subscription revenue trends; and corporate actions such as acquisitions, including the completed purchase of Ostro as a life sciences brand engagement platform.
Veeva Systems (NYSE: VEEV) unveiled findings from its Veeva Pulse Field Trends Report, highlighting a significant drop in healthcare professional (HCP) access, now at 45% compared to 60% eighteen months ago. The report underscores the effectiveness of a connected engagement model, where sales, marketing, and medical teams coordinate efforts to build more relevant and trusted HCP relationships. This approach helps biopharma companies overcome access barriers, increasing HCP engagement through digital and in-person touchpoints. The findings indicate that HCPs are more selective, often engaging with only three or fewer companies, and that specialties such as internal medicine, oncology, psychiatry, and urology have stricter access limitations. Despite these challenges, coordinated engagement has proven beneficial in extending conversations and improving treatment adoption.
Veeva Systems (NYSE: VEEV) announced that its Veeva MedTech platform has been named 'Best Overall MedTech Software' for the second consecutive year in the MedTech Breakthrough Awards. The award recognizes Veeva MedTech's innovation and excellence in helping medical device and diagnostic companies streamline processes through its unified cloud platform. Veeva MedTech's solutions, including Veeva Vault Clinical, RIM, Quality, Commercial, and Medical, offer comprehensive lifecycle management. Veeva partners with over 125 companies to enhance efficiency, speed, and compliance. This marks Veeva MedTech's third recognition by MedTech Breakthrough, following a win for 'Best Clinical Efficiency Solution' in 2022.
Veeva Systems (NYSE: VEEV) has launched Veeva Vault Basics, a new turnkey solution tailored for biotechs, which includes technology, training, and support with zero implementation and maintenance costs.
This offering allows biotechs to swiftly adopt industry-leading Veeva Vault applications, thereby enhancing efficiency, speed, and compliance. Currently, ten biotechs are using Vault Basics, which equips them with tools to manage growth effectively without additional costs.
The solution includes Vault eTMF Basics, Vault QualityDocs and Training Basics, and Vault Submissions and Submissions Archive Basics, providing a comprehensive suite for clinical trials, GxP document management, and regulatory submissions. Vault Basics is now available in North America, with additional offerings expected in 2025.
Veeva Systems (NYSE: VEEV) will release its fiscal 2025 first-quarter financial results on May 30, 2024, after the market closes. A conference call and webcast will be held at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss the results. Prepared remarks will be posted on Veeva's investor relations website before the call. A webcast replay will be available on the website after the event.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.